[ET Net News Agency, 30 December 2021] CMB International lowered its target price for
Kintor Pharma (09939) to HK$35.22 from HK$98.07 and maintained its "buy" rating.
The research house said it expects Pyrilutamide to file NDA for treatment of
androgenetic alopecia by end-2022E. (RC)